Interestingly, in these models CD5-2 treatment alone inhibited tumor growth by facilitating a spontaneous anti-tumor response, i.e., CD5-2 enhanced CD8+ T cell penetration into the center of tumors. This evidence concerns the gene CD8A and neoplasm.